Literature DB >> 11294730

New technology for detecting multidrug-resistant pathogens in the clinical microbiology laboratory.

L R Peterson1, G A Noskin.   

Abstract

Northwestern Memorial Hospital instituted in-house molecular typing to rapidly assess microbial clonality and integrated this typing into an infection control program. We compared data on nosocomial infections collected during 24 months before and 60 months after implementing the new program. During the intervention period, infections per 1,000 patient-days fell 13% (p=0.002) and the percentage of hospitalized patients with nosocomial infections decreased 23% (p=0.000006). In our hospital, the percentage of patients with nosocomial infections is 43% below the U.S. rate. Our typing laboratory costs approximately $400,000 per year, a savings of $5.00 for each dollar spent.

Entities:  

Mesh:

Year:  2001        PMID: 11294730      PMCID: PMC2631739          DOI: 10.3201/eid0702.010233

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  26 in total

1.  Molecular epidemiology of vancomycin-resistant enterococci: a 2-year perspective.

Authors:  V Stosor; J Kruszynski; T Suriano; G A Noskin; L R Peterson
Journal:  Infect Control Hosp Epidemiol       Date:  1999-10       Impact factor: 3.254

Review 2.  An overview of nosocomial infections, including the role of the microbiology laboratory.

Authors:  T G Emori; R P Gaynes
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

3.  Molecular epidemiology and its clinical application.

Authors:  J R Lupski
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

4.  Medical technologists using molecular epidemiology as part of the infection control team.

Authors:  L R Peterson; R A Petzel; C R Clabots; C E Fasching; D N Gerding
Journal:  Diagn Microbiol Infect Dis       Date:  1993 May-Jun       Impact factor: 2.803

5.  The nationwide nosocomial infection rate. A new need for vital statistics.

Authors:  R W Haley; D H Culver; J W White; W M Morgan; T G Emori
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

6.  Value of molecular epidemiologic analysis in a nosocomial methicillin-resistant Staphylococcus aureus outbreak.

Authors:  F C Fang; M McClelland; D G Guiney; M M Jackson; A I Hartstein; V H Morthland; C E Davis; D C McPherson; J Welsh
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

7.  Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems.

Authors:  C R Clabots; S Johnson; K M Bettin; P A Mathie; M E Mulligan; D R Schaberg; L R Peterson; D N Gerding
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Nosocomial infections. A college of American pathologists Q-probes study in 512 North American institutions.

Authors:  R B Schifman; P J Howanitz
Journal:  Arch Pathol Lab Med       Date:  1994-02       Impact factor: 5.534

9.  National nosocomial infections surveillance system (NNIS): description of surveillance methods.

Authors:  T G Emori; D H Culver; T C Horan; W R Jarvis; J W White; D R Olson; S Banerjee; J R Edwards; W J Martone; R P Gaynes
Journal:  Am J Infect Control       Date:  1991-02       Impact factor: 2.918

10.  Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization.

Authors:  G A Noskin; I Cooper; L R Peterson
Journal:  Arch Intern Med       Date:  1995-07-10
View more
  9 in total

Review 1.  Hunting health care-associated infections from the clinical microbiology laboratory: passive, active, and virtual surveillance.

Authors:  Lance R Peterson; Stephen E Brossette
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

2.  Contamination of the clinical microbiology laboratory with vancomycin-resistant enterococci and multidrug- resistant Enterobacteriaceae: implications for hospital and laboratory workers.

Authors:  S M Collins; D M Hacek; L A Degen; M O Wright; G A Noskin; L R Peterson
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  Optical fingerprinting in bacterial epidemiology: Raman spectroscopy as a real-time typing method.

Authors:  Diana F M Willemse-Erix; Maarten J Scholtes-Timmerman; Jan-Willem Jachtenberg; Willem B van Leeuwen; Deborah Horst-Kreft; Tom C Bakker Schut; Ruud H Deurenberg; Gerwin J Puppels; Alex van Belkum; Margreet C Vos; Kees Maquelin
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

5.  External quality assessment of molecular typing of Staphylococcus aureus isolates by a network of laboratories.

Authors:  A Deplano; R De Mendonça; R De Ryck; M J Struelens
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  Comparison of an automated repetitive-sequence-based PCR microbial typing system with pulsed-field gel electrophoresis for molecular typing of vancomycin-resistant Enterococcus faecium.

Authors:  Yu-Chung Chuang; Jann-Tay Wang; Mei-Ling Chen; Yee-Chun Chen
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

Review 7.  Application of molecular techniques to the study of hospital infection.

Authors:  Aparajita Singh; Richard V Goering; Shabbir Simjee; Steven L Foley; Marcus J Zervos
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  The Need for Dedicated Microbiology Leadership in the Clinical Microbiology Laboratory.

Authors:  Linoj P Samuel; Glen T Hansen; Colleen S Kraft; Bobbi S Pritt
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

Review 9.  Role of the microbiology laboratory in infectious disease surveillance, alert and response.

Authors:  R Cantón
Journal:  Clin Microbiol Infect       Date:  2005-04       Impact factor: 8.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.